{"filings":[{"id":1140796,"accession_number":"0001104659-26-075862","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K/A","filed_at":"2026-06-18T21:17:16+00:00","items":["9.01"],"status":"ready","headline":"Vireo Growth releases FY2025 financials for acquired Hawthorne Business: revenue $130.2M, net loss $9.6M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Hawthorne had net sales of $130.2M and net loss of $9.6M for fiscal year ended Sept 30, 2025.","Gross margin was $25.4M (19.5% of sales), after $7.0M impairment/restructuring in cost of sales.","Operating loss before tax was $10.9M; SG&A expenses totaled $33.0M.","Total assets $111.6M, liabilities $37.8M, net parent investment $73.8M; used $8.9M operating cash."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1138323,"accession_number":"0001104659-26-075721","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-06-18T20:05:40+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Vireo Growth to acquire C21 Investments in all-stock deal; exchange ratio 0.023052","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Each C21 share exchanged for 0.023052 Vireo subordinate voting shares; C21 shareholders to vote in Q3 2026.","Acquisition adds ~15 Nevada dispensaries and 158,000 sq ft of cultivation/manufacturing capacity.","Termination fee of $3M payable by C21 in certain circumstances; outside date May 31, 2027.","Transaction requires C21 shareholder approval (2/3 majority), court orders, and regulatory approvals.","C21 board and special committee unanimously recommend deal; Needham & Co. provided fairness opinion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1000239,"accession_number":"0001104659-26-072943","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K/A","filed_at":"2026-06-11T20:12:59+00:00","items":["9.01"],"status":"ready","headline":"Eaze FY2025 net loss $24.1M on $141M revenue; Vireo merger closed Apr 1, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Eaze FY2025 revenue $141.1M; gross profit $59.0M (41.8% margin).","Operating loss $10.6M; net loss $24.1M after $12.8M income tax provision.","Total assets $101.8M, liabilities $83.1M, equity $18.8M at Dec 31, 2025.","Cash used in operations $7.0M; cash balance $3.3M; long-term debt $5.2M current portion.","Vireo Growth Inc. completed Eaze acquisition on April 1, 2026 (prior disclosure)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":999956,"accession_number":"0001104659-26-072936","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-06-11T20:06:08+00:00","items":["1.01","2.03","3.02","7.01","9.01"],"status":"ready","headline":"Vireo Growth closes $13.66M Bridgewell acquisition; plans Nevada and Maryland dispensary buys","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed Bridgewell acquisition for ~$13.66M in convertible notes; converts after 2 years into ~22M shares at $0.62/share.","Assumed ~$30.35M debt, including $22M senior facility from Chicago Atlantic; CEO Mazarakis is affiliate of lender.","Plans to acquire Nevada dispensary (M3 Wellness, $500K) and 49% of Maryland dispensaries (HA-MD, $1.55M); both pending approvals.","Consideration includes subordinate voting shares: 416,667 for Nevada and 1,111,110 for Maryland, at ~$0.675/share."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":999958,"accession_number":"0001104659-26-072935","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-06-11T20:05:53+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Vireo Growth approves 30-for-1 share consolidation effective June 5, 2026","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Shareholders approved consolidation range of 20-to-1 to 40-to-1 at May 29 annual meeting; Board set 30-for-1 ratio on June 1.","Outstanding subordinate voting shares reduced from ~1.455 billion to ~48.5 million; multiple voting shares from 232,490 to ~7,749.","No fractional shares issued; fractional entitlements rounded down to nearest whole share; ownership percentages unchanged.","Post-consolidation shares will trade under same symbols VREO (CSE) and VREOF (OTCQX) with new CUSIP 92767B204."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":947237,"accession_number":"0001104659-26-071886","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-06-09T20:52:33+00:00","items":["4.01","7.01","9.01"],"status":"ready","headline":"Vireo Growth appoints BDO as new auditor, dismisses Davidson","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Auditor changed from Davidson & Company LLP to BDO USA, P.C., effective June 5, 2026.","No disagreements or reportable events between Vireo and Davidson during past two fiscal years.","Appointment and dismissal approved by Board and Audit Committee.","CEO cites BDO's global capabilities and alignment with M&A growth strategy in cannabis market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":833600,"accession_number":"0001104659-26-070099","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-06-03T20:06:11+00:00","items":["5.07"],"status":"ready","headline":"Vireo Growth shareholders approve share consolidation (20:1-40:1) and CEO employment amendment at AGM","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees elected; Dr. Kyle E. Kingsley and others received over 572M votes for.","Share consolidation approved: ~622.8M for, ~1.0M against; ratio range 20:1 to 40:1 at Board discretion.","CEO John Mazarakis employment agreement second amendment approved (~446.8M for, ~31.4M against, 94.9M abstentions).","Securities distribution to Mazarakis under the amendment also approved (~459.1M for, ~19.2M against, 94.9M abstentions).","Davidson & Company LLP appointed as auditors with ~631.1M votes for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":746558,"accession_number":"0001104659-26-068242","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-05-29T20:06:02+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Vireo Growth acquires NY cannabis facility from IIP for $88.5M with $49M seller note and $41M loan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Purchased 389,000 sq ft cultivation/production facility in Perth, NY from IIP-NY 2 LLC for $88.5M.","Seller financing of $49M note at 15% interest, matures May 25, 2027, with two one-year extension options.","Chicago Atlantic loan of $41M at prime+5.75%, matures May 28, 2028, second lien subordinated to seller note.","Buyer subsidiary 256 County Route 117 Perth LLC; obligations guaranteed by Vireo and Vireo Health, Inc.","Facility previously leased; purchase option exercised under existing lease agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":22487,"accession_number":"0001104659-26-059005","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-05-12T11:30:08+00:00","items":["2.02","9.01"],"status":"ready","headline":"Vireo Growth Q1 revenue $106.2M (+333.5% YoY); closes multiple acquisitions","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $106.2M, up 333.5% YoY; GAAP gross profit $59.3M (55.8% margin).","Adjusted EBITDA $32.7M, up 395.5% YoY; margin 30.8%.","Closed Schwazze acquisition and PharmaCann MSA during Q1; acquired Eaze and Hawthorne post-quarter.","Announced definitive agreement to acquire FLUENT and JV with Glass House Brands post-quarter.","Ended Q1 with $137.8M cash; expects to remain acquisitive."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":106200000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95339,"accession_number":"0001104659-26-055624","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Vireo Growth to acquire FLUENT in all-stock deal; exchange ratio 0.0705359","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["FLUENT shareholders receive 0.0705359 Vireo shares per share; transaction structured as court-approved plan of arrangement under Ontario law.","FLUENT generated ~$71.5M in Florida revenue in 2025; combined Florida platform to have ~74 stores and 144k sq ft cultivation/production canopy.","US$30M of FLUENT senior secured debt equitized into shares that convert to Vireo shares at closing, reducing post-closing leverage.","Transaction requires approval of 2/3 of FLUENT shareholders, court final order, and regulatory clearances; expected to close by March 31, 2027.","Termination fee of $2M payable by FLUENT in certain scenarios; Vireo shares issued exempt from US registration under Section 3(a)(10)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95338,"accession_number":"0001104659-26-043175","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-04-14T23:59:59+00:00","items":["1.01","2.02","3.02","7.01","9.01"],"status":"ready","headline":"Vireo Growth acquires Hawthorne Gardening, gains $110M cash+NWC, pays 213M shares + 80M warrants","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Vireo issued 213M shares (deemed $0.60) and 80M warrants ($0.85 strike) to Good Dog (Scotts designee) for Hawthorne.","Acquired ~$35M cash, ~$58M net working capital, and $20M inventory supply over 2 years from Hawthorne.","Chris Hagedorn, Scotts EVP, nominated to Vireo board at May 29 AGM.","Good Dog owns ~14% of Vireo; if warrants exercised would own ~19%.","Lock-up: 10% at 6 months, 30% at 12/18/24 months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95337,"accession_number":"0001104659-26-039924","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-04-06T23:59:59+00:00","items":["1.01","2.01","3.02","5.02","7.01","8.01","9.01"],"status":"ready","headline":"Vireo closes Eaze acquisition for $47M in stock; CEO awarded performance-based RSUs up to 3.5% diluted","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed Eaze merger on April 1; issued 90.4M shares at $0.56 per share (base consideration $47.04M).","Potential earnout up to additional shares based on $76.8M imputed EBITDA with share price floor of $1.05.","CEO Mazarakis gets base salary increase to $2.25M (conditional on $1B market cap or Jan 2027) and 10M annual shares for 5 years from 2027.","Board appointed Michael Steiner as director; CEO also receives multi-phase RSUs (up to 2.5% per phase) conditional on shareholder approval.","NY subsidiary restructured: Ace gets 51% interest; Vireo issues $16M note at 7% to VHI."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108309,"accession_number":"0001104659-26-036876","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Vireo Growth delivers 90.7M shares into escrow for PharmaCann asset deal; closing expected Q2'26","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["MSA with PharmaCann effective March 22, 2026; Vireo to manage Colorado retail assets until closing.","Vireo delivered 90,740,741 subordinate voting shares into escrow as consideration under APA.","Closing of asset acquisition expected in Q2 2026, subject to regulatory approval.","Shares held in escrow with Odyssey Trust Company pending release at closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108308,"accession_number":"0001104659-26-034509","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-03-25T23:59:59+00:00","items":["1.01","2.01","2.03","7.01","9.01"],"status":"ready","headline":"Vireo Growth closes acquisition of Schwazze's 45 dispensaries and 2 manufacturing facilities","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired 24 Colorado dispensaries, 21 New Mexico dispensaries, and one manufacturing facility in each state.","Implied estimated valuation under 4x pro forma EBITDA; credit bid of ~$111M in Senior Secured Notes.","Justin Dye appointed Chairman of Colorado/New Mexico business; Forrest Hoffmaster named CEO of those operations.","NewCo entered into $50M Tranche A and $12.7M Tranche B term loans; CO Acquisition closed $26M facility.","Transaction expands Vireo's retail footprint to over 75 dispensaries in Colorado and New Mexico over time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108307,"accession_number":"0001104659-26-028946","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2026-03-17T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Vireo Growth Q4 revenue $104.5M (+318% YoY); pro forma same-store sales +22%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP revenue $104.5M, up 317.7% YoY; gross profit margin 54.4% vs 50.6%.","Pro forma same-store sales up 22% YoY; wholesale revenue up 55% YoY; ex-Minnesota same-store sales +11.3%.","Adjusted EBITDA $29.5M (margin 28.2%), up 347% YoY; pro forma Adj. EBITDA up 30%.","Ended Q4 with $122.5M cash; expects to close acquisitions of Eaze, Schwazze, PharmaCann (CO) and Hawthorne in H1 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124762,"accession_number":"0001104659-25-125248","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-12-30T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"Vireo Growth acquires Eaze for ~$47M in stock, expanding to CA, FL, CO","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Base consideration ~$47M in ~84M subordinate voting shares at $0.56 per share.","Acquisition adds 65 retail locations in CA, FL, CO; total footprint to 166 dispensaries across 10 states.","Earn-out based on 2026 EBITDA at 3.84x, payable in shares at higher of $1.05 or 20-day VWAP.","Closing expected first half 2026, subject to regulatory approvals and CSE approval.","Sellers' shares subject to lock-up with staggered releases through March 2028."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124761,"accession_number":"0001104659-25-124843","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-12-29T23:59:59+00:00","items":["3.02","8.01","7.01","9.01"],"status":"ready","headline":"Vireo Growth to acquire $2.6M face value of Schwazze notes for $1.6M in stock, reaching 89% ownership","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Acquiring ~$2.6M face value (principal + interest) of Schwazze's 13% Senior Secured Convertible Notes for ~$1.6M in subordinate voting shares at $0.54/share.","Upon closing, Vireo will own approximately 89% of the total outstanding Notes.","Schwazze is currently in default on payment obligations under the Notes; maturity is December 7, 2026.","CEO John Mazarakis is a partner of Chicago Atlantic Group, an affiliate of the collateral agent (related-party transaction).","Closing expected by December 31, 2025, subject to Canadian Stock Exchange approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124760,"accession_number":"0001104659-25-123459","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-12-22T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Vireo Growth to acquire 17 Colorado dispensaries from PharmaCann for ~$49M in shares","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Vireo enters APA to buy 17 Colorado dispensaries from PharmaCann; total consideration ~$49M in Vireo subordinate voting shares plus liability assumption.","Deal expands Vireo's Colorado retail presence to 41 dispensaries; closing expected in 1H'26 subject to regulatory approvals.","Management Services Agreement signed; Vireo subsidiary will operate the dispensaries through closing.","Share consideration subject to adjustment based on inventory and payables; restricted under Canadian securities law and CSE."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124759,"accession_number":"0001104659-25-119847","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-12-10T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Vireo Growth wins $111M credit bid for Schwazze assets, forms NewCo","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Vireo subsidiary credit bid ~$111M of Schwazze 13% Senior Secured Notes, winning asset sale.","Asset sale conducted Nov 13, 2025 under UCC §9-610/611; RSA signed Oct 10, 2025.","NewCo to acquire majority of Schwazze assets; Vireo will be majority owner post-closing.","Closing subject to regulatory approvals and satisfaction of conditions in asset purchase agreement.","Remaining Schwazze assets to be liquidated; winding down of operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124758,"accession_number":"0001104659-25-109800","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Vireo Q3 revenue jumps 264% YoY to $91.7M; adjusted EBITDA $25.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue of $91.7M (+264% YoY); GAAP gross profit $37.4M (40.8% margin, down 820 bps).","Adjusted operating income $21.0M (+304% YoY); adjusted EBITDA $25.4M (+297% YoY).","Completed refinancing of senior secured debt, expected to cut annualized interest expense by $10M.","Ended Q3 with $117M cash; plans to remain acquisitive in distressed market.","Q3 2025 GAAP operating income $0.8M vs $3.9M YoY, down 79% due to deal-related costs."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":164258806.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124757,"accession_number":"0001104659-25-105541","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Vireo Growth settles litigation with Verano for ~US$10M in assets and cash","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Settlement dismisses all outstanding litigation between Vireo and Verano in British Columbia Supreme Court.","Value to Vireo is approximately US$10M: acquisition of real estate assets plus US$1M cash.","Litigation began Oct 2022 related to Jan 2022 arrangement agreement between the companies.","Boards of both companies approved the settlement terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124756,"accession_number":"0001104659-25-099334","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-10-14T23:59:59+00:00","items":["1.01","2.01","3.02","7.01","9.01"],"status":"ready","headline":"Vireo acquires 86% of Schwazze's senior secured notes for $62M in shares; enters RSA to take control of assets","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired ~$91M face value (principal + interest) of Schwazze's 13% Senior Secured Notes for ~$62M in 114.8M subordinate voting shares at $0.54/share.","Restructuring Support Agreement (RSA) signed: Vireo-led credit bid targets acquisition of majority of Schwazze's assets via UCC sale; auction set for Nov 14, 2025.","NewCo to receive up to $62M in financing to refinance Schwazze's Star Bud seller notes and provide working capital.","Schwazze operates 63 dispensaries and 10 manufacturing facilities in Colorado and New Mexico.","Closing conditions include regulatory approvals; Schwazze notes currently in default."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124755,"accession_number":"0001104659-25-097924","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-10-08T23:59:59+00:00","items":["1.01","3.02","7.01","9.01"],"status":"ready","headline":"Vireo Growth to acquire ~86% of Schwazze's senior secured notes for $62M in stock","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquiring ~86% of Schwazze's 13% Senior Secured Convertible Notes due Dec 2026 for ~$62M in subordinate voting shares.","Notes have aggregate value of ~$91M (principal+accrued interest); consideration implies a discount.","Shares issued at deemed price of $0.54 per VREO share; expected close by Oct 31, subject to CSE approval.","Schwazze is currently in default on payment obligations under the Notes.","CEO John Mazarakis is a partner of Chicago Atlantic Group, affiliate of collateral agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141452,"accession_number":"0001558370-25-011303","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Vireo Q2 GAAP revenue $48.1M (+91% YoY); operating loss of $2.0M vs prior profit","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $48.1M (+91% YoY); gross profit $20.4M (+50%). Gross margin fell 1,150 bps to 42.5%.","GAAP operating loss $2.0M vs income of $5.8M in Q2 2024; adjusted operating income $11.3M (+98%).","Adjusted EBITDA $13.3M (margin 27.6%); SG&A as % of revenue improved 480 bps to 25.4%.","Closed previously pending merger transactions in Q2; pro forma results in line with expectations.","Completed $153M refinancing, leaving company with over $100M cash and lower cost of capital."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":72603651.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141450,"accession_number":"0001558370-25-010924","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K/A","filed_at":"2025-08-08T23:59:59+00:00","items":["9.01"],"status":"ready","headline":"Vireo Growth files Q1 2025 unaudited financials for acquired Proper Holdings and Deep Roots","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Proper Holdings net sales $21.4M in Q1 2025, down from $23.0M in Q1 2024.","Proper Holdings net income fell to $0.15M from $3.77M YoY; members' equity $25.4M at March 31, 2025.","Acquisitions closed June 5-6, 2025; pro forma combined financials also filed.","Deep Roots unaudited Q1 2025 financials filed but not detailed in this excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141451,"accession_number":"0001104659-25-067451","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-07-11T23:59:59+00:00","items":["1.01","2.03","3.02","5.02","7.01","9.01"],"status":"ready","headline":"Vireo closes $153M refinancing; expects $10M+ annual interest savings","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Closed $120M first lien term loan at 8.3% interest with bank syndicate; oversubscribed.","Closed $33M second lien term loan with $50M accordion from Chicago Atlantic.","Proceeds used to retire ~$114M existing senior debt, recapture $10M from WholesomeCo merger, and refinance $10M convertible note.","Expected annual interest savings of more than $10M; balance sheet strengthened with over $100M cash.","CEO Mazarakis may receive bonus of 0.8% of refinanced principal; CFO Macdonald 0.4%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159271,"accession_number":"0001104659-25-061663","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-06-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Vireo Growth annual meeting elects all five director nominees; auditor ratified","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual general meeting held June 20, 2025; quorum present.","Five director nominees elected: Kyle E. Kingsley, Ross M. Hussey, Victor E. Mancebo, Judd T. Nordquist, John Mazarakis.","Each director received over 167 million votes for; broker non-votes of 37.5 million.","Proposal #2: Appointment of Davidson & Company LLP as auditor approved with 205.8 million for, 1.0 million against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159270,"accession_number":"0001558370-25-008683","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-06-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Vireo Growth pro forma Q2 2025 revenue guidance $88-91M; expects >$100M cash after debt refinancing","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Pro forma Q2 2025 revenue expected $88-$91M, adjusted EBITDA $23-$24M, assuming mergers closed April 1.","Mergers closed make Vireo one of largest US multi-state cannabis operators with six-state portfolio.","Signed multiple non-binding term sheets to refinance all senior secured debt; targeting expedited close with >$100M cash.","Shares outstanding: 949,254,483 basic as-converted; 1,087,283,616 fully diluted."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159269,"accession_number":"0001104659-25-058908","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["1.01","2.01","2.03","3.02","7.01","9.01"],"status":"ready","headline":"Vireo closes $132.7M acquisition of Nevada cannabis operator Deep Roots; 255.2M shares issued","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Consideration 255.2M Vireo shares at $0.52/share; multiple 4.175x 2024 Closing EBITDA of $30M.","Deep Roots operates 54,000 sq ft cultivation facility and 10 retail dispensaries in Nevada.","Selling shareholders subject to 33-month voluntary lock-up with tranche releases.","Earn-out and clawback provisions based on 2026 EBITDA vs Closing EBITDA; max clawback 50% of shares.","Vireo assumed ~$19.2M debt under CA Loan Agreement at Prime +6.5%, maturing Aug 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159265,"accession_number":"0001104659-25-058898","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K/A","filed_at":"2025-06-12T23:59:59+00:00","items":["2.03","2.01","9.01"],"status":"ready","headline":"Vireo Growth assumes ~$25.5M debt via CA Loan Agreement at 11% interest, maturing Nov 2025","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Debt of ~$25.5M assumed from acquisition; 11% cash interest plus 2%-3% PIK interest based on leverage.","Monthly principal payments of 1% of aggregate principal; maturity date November 28, 2025.","Standard events of default allow acceleration and 9% interest rate increase upon default.","Vireo guaranteed borrowers' obligations; prior entities Holdings and New Growth Horizon released."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159268,"accession_number":"0001104659-25-057335","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["1.01","2.01","3.01","7.01","9.01"],"status":"ready","headline":"Vireo Growth closes $102M acquisition of Proper Brands in Missouri","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration $102M paid with 196.2M subordinate voting shares at $0.52 reference price.","Transaction valued at 4.175x 2024 Closing EBITDA of $31M; clawback provision if 2026 EBITDA falls below.","Shares subject to 33-month lock-up with tranched unlocks; 10% placed in escrow for post-closing adjustments.","CEO John Mazarakis holds ~29% interest in Acquired Companies' debt via Chicago Atlantic; net debt ~$27.4M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159267,"accession_number":"0001104659-25-047350","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["1.01","2.01","3.01","5.02","7.01","9.01"],"status":"ready","headline":"Vireo closes $69.8M WholesomeCo & Arches acquisition; issued 134.2M shares at $0.52","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration of $69.8M paid in 134.2M subordinate voting shares at $0.52 reference price.","Deal represents 4.175x 2024 Reference EBITDA of $16M; includes earn-out and clawback provisions through 2026.","Selling shareholders subject to lock-up with tranches releasing over 33 months.","Other pending mergers in Missouri and Nevada remain on track to close in Q2 2025.","Issued 19M time- and 19M performance-vested RSUs to CEO Mazarakis; 9.5M each type to CFO Macdonald."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159266,"accession_number":"0001104659-25-046502","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Vireo Growth Q1 revenue $24.5M (+1.9% YoY); Adjusted EBITDA $6.6M (+8.5%); merger close expected Q2","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $24.5M (+1.9% YoY); gross profit margin 50.6% (flat YoY).","Operating income $2.0M (-58.5% YoY); Adjusted EBITDA $6.6M (+8.5%, margin 26.8%).","Cash $86.3M; 472M shares outstanding at $0.45 per share (treasury method).","Merger transactions expected to close in Q2 2025; shareholder approvals and Utah regulatory approvals obtained.","Growth in Maryland; stable Minnesota; NY medical declined but adult-use sales commenced from indoor facility."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":24540641.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177702,"accession_number":"0001104659-25-026121","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-03-20T23:59:59+00:00","items":["1.01","5.07","9.01"],"status":"ready","headline":"Vireo Growth amends merger agreements for Proper, Deep Roots, Wholesome; shareholders approve deals","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Amendments adjust earnout calculation (greater of $37.5M or 5x revenue minus $4M) and soften forfeiture triggers.","Majority shareholders (51.5% voting power) approve mergers, share issuance at $0.52, and RSU grants to CEO/CFO.","Proper merger forfeiture now triggered solely by EBITDA shortfall of $31M; market share/EBITDA margin conditions removed.","CEO Mazarakis granted 19M time-based and 19M performance-based RSUs; CFO Macdonald receives 9.5M each.","Deep Roots and Wholesome amendments clarify no additional shares from surviving companies, except for conversion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177701,"accession_number":"0001104659-25-021954","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Vireo Growth amends CEO and CFO employment agreements; RSUs tied to stock price and EBITDA targets","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Mazarakis: 19M Time-Vested RSUs now vest 30% at year 1, 35% at $0.85 VWAP year 2, remaining at $1.05 VWAP year 3.","CEO Performance-Vested RSUs (19M) vest in thirds when AEBITDA exceeds $150M, $165M, $205M and net leverage <2.2x.","CFO Macdonald: 9.5M Time-Vested RSUs with same VWAP-based vesting; 9.5M Performance-Vested RSUs tied to same AEBITDA targets.","Debt refinance bonus threshold lowered from $80M to $60M; CEO bonus 0.8%, CFO 0.4% (down from 1%).","Transaction bonus tied to acquisition multiple ≤5x TEV; sale bonus triggers at $1.15+ per share; capital raise bonus unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177700,"accession_number":"0001558370-25-002104","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-03-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Vireo Growth FY2024 revenue $99.4M (+15.4%); adjusted EBITDA $25.1M (+28.4%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Record FY2024 revenue of $99.4M (ex-discontinued ops +15.4% YoY); gross margin expanded 110 bps to 51.1%.","FY2024 operating income $13.6M (+28.2%); adjusted EBITDA $25.1M with margin of 25.3%.","Q4 revenue $25.0M (+3.5% YoY) flat sequentially; operating loss of $0.8M due to $4.2M merger transaction expenses.","Ended FY2024 with $91.6M cash after $81M oversubscribed private placement at $0.625/share (16.8% premium).","Minnesota adult-use launch and pending merger transactions position for transformational 2025; two new credit facilities for cultivation capacity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177699,"accession_number":"0001104659-25-006327","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-01-27T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Vireo Growth extends exclusivity period for proposed transaction with Bill's Nursery to Feb 23, 2025","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Extension of exclusivity period; MOU effective Dec 18, 2024 proposes transaction involving U.S. affiliate of Vireo and Bill's Nursery.","Exclusivity period extended from January 24, 2025 to February 23, 2025 via letter agreement dated January 23, 2025.","No financial or other terms of the proposed transaction were disclosed in the filing.","Parties' obligations under the MOU remain otherwise unchanged except for the exclusivity extension."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177697,"accession_number":"0001104659-25-001369","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K/A","filed_at":"2025-01-06T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Vireo Growth closes oversubscribed $81M equity offering at $0.625/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Closed on Dec 30, 2024, issuing 129.5M subordinate voting shares at US$0.625 each, a 16.8% premium to the Dec 27 OTCQX close.","Gross proceeds of ~$81M, exceeding the initially planned $75M; proceeds earmarked for organic and acquisitive growth, working capital, and general corporate purposes.","Chicago Atlantic formed a special purpose vehicle to participate; transaction deemed a related party transaction but exempt from formal valuation and minority approval under MI 61-101.","Six-month lock-up on shares from closing date; Lineage Merchant Partners acted as placement agent via GT Securities.","Securities issued under exemptions from U.S. and Canadian registration; no public offering."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":177698,"accession_number":"0001104659-25-000793","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2025-01-03T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Vireo Growth enters $26.5M in secured credit facilities for Minnesota cultivation buildout","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Chicago Atlantic Credit Agreement: up to $11.5M ($5.5M funded at close); 10.5% interest, maturity June 26, 2026.","Stearns Bank Commercial Loan: $15M, 9.25% fixed, 24-month term, interest-only first 12 months, no prepayment penalty.","Loans secured by Vireo Minnesota's Elk River leasehold and business assets, plus a mortgage on vacant land in Massachusetts.","Proceeds to fund buildout of a new cultivation facility in an existing industrial building in Elk River, Minnesota."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194422,"accession_number":"0001104659-24-131371","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-12-23T23:59:59+00:00","items":["1.01","3.01","5.02","7.01","9.01"],"status":"ready","headline":"Vireo Growth to acquire Deep Roots, Proper, WholesomeCo for shares at $0.52 reference price","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["All-share mergers with Deep Roots (Ref. EBITDA $31M), Proper ($31M), and WholesomeCo ($16M) at $0.52/share reference price.","Conditions include $75M equity investment, appointment of John Mazarakis as CEO and Co-Executive Chairman, and John Pennington as director.","Earnout payments after Dec 31, 2026 based on EBITDA growth at 4x multiple; up to 50% of upfront consideration subject to clawback if EBITDA underperforms 96.5% of Ref. EBITDA.","Lock-up agreements with staggered release over 33 months, with all shares locked up during 6-month period ending Dec 31, 2026.","Termination fees: $6.4M (Deep Roots), $4.6M (Proper), $3.4M (WholesomeCo)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194421,"accession_number":"0001104659-24-115288","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["1.01","2.03","3.02","7.01","9.01"],"status":"ready","headline":"Vireo Growth secures $10M convertible debt facility with 12% interest, $0.625 conversion","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Up to $10M convertible notes; maturity Nov 1, 2027; cash interest 12% paid monthly.","Conversion price $0.625; convertible at lender's option in whole at any time.","No warrants; facility from existing senior secured lender and affiliates.","Proceeds for capex, working capital, general corporate purposes; tied to Minnesota adult-use launch.","Considered related party transaction under MI 61-101; exempt from formal valuation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194420,"accession_number":"0001104659-24-108300","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-10-15T23:59:59+00:00","items":["1.02","5.02","7.01","9.01"],"status":"ready","headline":"Vireo Growth CEO Joshua Rosen resigns; Amber Shimpa appointed CEO; terminates Grown Rogue agreement","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joshua Rosen resigns as CEO, interim CFO, and director; receives 500k RSUs, 500k options, salary continuation $300k/yr for 2 years.","Amber Shimpa, previously President, promoted to CEO; receives $325k base salary and 1M stock options.","Joe Duxbury appointed interim CFO; company searches for permanent replacement.","Terminates consulting agreement with Grown Rogue; forfeits 4.5M of 8.5M warrants; termination fee $800k lump sum or $1M in installments.","Rosen retained as consultant for litigation matters at $1,000/hour; vested 250k options accelerated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210743,"accession_number":"0001104659-24-086082","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["1.01","3.02","7.01","8.01","9.01"],"status":"ready","headline":"Vireo Growth extends credit facility to Jan 2027; converts $10.5M notes into 73M shares","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Ninth Amendment extends credit facility maturity to Jan 29, 2027, waives default on NY disposition, extends deadline to July 31, 2025.","Company issued 12,500,000 subordinate voting shares to lenders as consideration for the amendment.","Chicago Atlantic voluntarily converted all $10.5M convertible notes (12% rate, $0.145 strike) into ~73M subordinate voting shares.","Early conversion saves $1.2M in cash interest and $1.1M in PIK interest, totaling $2.3M in interest expense savings.","Conversion reflects lender confidence in Vireo's operational improvements and positions company for adult-use sales in Minnesota."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":210742,"accession_number":"0001104659-24-076846","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-07-01T23:59:59+00:00","items":["5.0","7.01","9.01"],"status":"ready","headline":"Goodness Growth Holdings changes name to Vireo Growth Inc.; new tickers VREO/VREOF expected July 8","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company changed name from Goodness Growth Holdings to Vireo Growth Inc. effective July 3, 2024.","Subordinate voting shares expected to trade as VREO on CSE and VREOF on OTCQX starting July 8, 2024, pending final regulatory approval.","No share consolidation or exchange of certificates required; existing certificates remain valid.","New CUSIP 92767B105 and ISIN CA92767B1058 for subordinate voting shares.","CEO Josh Rosen stated name change reflects return to roots as cannabis operator."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229129,"accession_number":"0001558370-24-009441","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-06-24T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Shareholders approve all five proposals at June 21 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Fixed number of directors at five for ensuing year (63.7M for, 0.4M against).","Elected all five nominees: Kingsley, Hussey, Mancebo, Nordquist, Rosen.","Ratified 2019 Incentive Plan (33.5M for, 6.5M against; 23.9M broker non-votes).","Ratified awards granted since March 2022 under the 2019 Incentive Plan (33.4M for).","Appointed Davidson & Company LLP as auditors (63.8M for)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229128,"accession_number":"0001104659-24-073109","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-06-20T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Goodness Growth Holdings extends credit facility delayed draw loan maturity to July 31, 2024","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Eighth Amendment to Credit Facility executed June 14, 2024.","Maturity date on delayed draw loans extended to July 31, 2024.","Parties include Company, subsidiaries, guarantors, lenders, and Chicago Atlantic Admin as agent.","Full amendment text to be filed with Q2 2024 10-Q."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229127,"accession_number":"0001104659-24-069083","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-06-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"EVP Retail Patrick Peters resigns; CEO Joshua Rosen granted 121,625 RSUs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Patrick Peters, EVP of Retail of subsidiary Vireo Health, resigned effective June 14, 2024; no disagreement.","On May 31, 2024, CEO Joshua Rosen received 121,625 RSUs under the 2019 Equity Incentive Plan.","RSUs vest upon earliest of Dec 31, 2026, termination w/o Cause, or resignation for Good Reason.","Grant was made pursuant to Rosen's employment agreement effective Jan 1, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229126,"accession_number":"0001558370-24-006688","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-05-06T23:59:59+00:00","items":["1.0","5.02","7.01","9.01"],"status":"ready","headline":"Goodness Growth appoints Josh Rosen permanent CEO; extends credit to June 14, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Josh Rosen, formerly Interim CEO and CFO, appointed CEO effective May 1, 2024; will continue as Interim CFO.","Seventh Amendment to credit facility extends Delayed Draw Loan maturity to June 14, 2024; discussions ongoing for longer-term extension.","Company plans corporate name change to Vireo in coming months; expects to announce ticker symbols later."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229125,"accession_number":"0001104659-24-048076","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-04-17T23:59:59+00:00","items":["5.08","8.01","9.01"],"status":"ready","headline":"Goodness Growth Holdings sets June 21, 2024 annual meeting; record date May 7, 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Last annual meeting held November 20, 2022; company received BCBCA extension in December 2023 to hold 2023 meeting.","Shareholder proposals under Rule 14a-8 must be received by April 29, 2024 for inclusion in proxy.","Universal proxy rule notice for director nominees other than company's must be submitted by April 22, 2024.","Advance notice policy sets director nomination window from April 17 to May 22, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":229124,"accession_number":"0001104659-24-044241","cik":1771706,"company_name":"Vireo Growth Inc.","ticker":"VREOF","form_type":"8-K","filed_at":"2024-04-05T23:59:59+00:00","items":["1.0","9.01"],"status":"ready","headline":"Goodness Growth enters binding LOI to sell VireoNY assets to ACE for $3-5M; closes by June 30","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $3-5M for VireoNY licenses, inventory, assets; ACE assumes IIP lease for Johnstown campus.","ACE to invest $20M to develop license and support IIP lease transfer; acquires two-year purchase option on campus.","Goodness provides $2.5M unsecured loan to VireoNY; ACE may issue additional $5M loan with price adjustments.","Goodness retains 15% net profit interest via advisory agreement; ACE can buy out for fair market value.","Closing expected by June 30, 2024, subject to regulatory approval and definitive agreements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":733700000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-04-05T23:59:59+00:00|229124"}